Showing results (1341-1350 of 1,826) with videos related to
Sort By:
Pageof 183
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|May 3, 2018
Preemptive treatment of early donor-specific antibodies with IgA- and IgM-enriched intravenous human immunoglobulins in lung transplantationFabio Ius, Murielle Verboom, Wiebke Sommer, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 16, 2004
Outcome of allogeneic hematopoietic stem-cell transplantation in adult patients with acute lymphoblastic leukemia: no difference in related compared with unrelated transplant in first complete remissionMichael G Kiehl, Ludwig Kraut, Rainer Schwerdtfeger, et al.Haematologica|July 22, 2008
Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantationFrancis Ayuk, José A Perez-Simon, Avichai Shimoni, et al.Haematologica|January 7, 2014
Allogeneic hematopoietic stem cell transplantation in patients with polycythemia vera or essential thrombocythemia transformed to myelofibrosis or acute myeloid leukemia: a report from the MPN Subcommittee of the Chronic Malignancies Working Party of the European Group for Blood and Marrow TransplantationFederico Lussana, Alessandro Rambaldi, Maria Chiara Finazzi, et al.Blood|December 15, 2011
Treatment, risk factors, and outcome of adults with relapsed AML after reduced intensity conditioning for allogeneic stem cell transplantationChristoph Schmid, Myriam Labopin, Arnon Nagler, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 11, 2015
Outcomes of Cord Blood Transplantation Using Reduced-Intensity Conditioning for Chronic Lymphocytic Leukemia: A Study on Behalf of Eurocord and Cord Blood Committee of Cellular Therapy and Immunobiology Working Party, Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation, and the Societé Française de Greffe de Moelle et Therapie CellulaireErick Xavier, Jérôme Cornillon, Annalisa Ruggeri, et al.Public Health|September 6, 2025
Adolescent pregnancy in French Guiana: double trouble for young mothers and small vulnerable newbornsLindsay Osei, Françoise Vendittelli, Mathilde Georgeault, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 24, 2016
CD25 Blockade Delays Regulatory T Cell Reconstitution and Does Not Prevent Graft-versus-Host Disease After Allogeneic Hematopoietic Cell TransplantationFrederick L Locke, Joseph Pidala, Barry Storer, et al.Bone Marrow Transplantation|February 24, 2021
Hematopoietic cell transplantation and cellular therapy survey of the EBMT: monitoring of activities and trends over 30 yearsJakob R Passweg, Helen Baldomero, Christian Chabannon, et al.The New England Journal of Medicine|January 8, 2025
Clearance of Driver Mutations after Transplantation for MyelofibrosisNico Gagelmann, Marie Quarder, Anita Badbaran, et al.Pageof 183